Scout GTM brain

Scout is developing portable molecular diagnostic testing for clinics, communities and eventual at-home care.

category

Point-of-care molecular diagnostics

market profile

  • text: Clinics face a trade-off between rapid antigen tests and slower central laboratory molecular testing.
  • text: Scout is developing a gonorrhea and chlamydia test for point-of-care and over-the-counter use with CARB-X funding.

personas

  • title: Primary care or sexual health clinic medical director
    pains:
    • Lab turnaround can delay treatment and lose patients to follow-up
    • Needs reliable actionable tests during a visit
  • title: Community health program director
    pains:
    • Limited laboratory access in remote or resource-constrained settings
    • Needs portable testing with low operational burden
  • title: Diagnostics procurement and clinical operations lead
    pains:
    • Must assess test cost, reimbursement, workflow and regulatory status
    • Cannot assume investigational performance claims have FDA review

icp

  • text: Primary care and sexual health clinics seeking molecular results during a patient visit.
  • text: Community and remote-care providers with limited access to central labs, subject to applicable regulatory authorization.

message pillars

  • text: Provide portable molecular testing closer to care.
  • text: Help close the gap between testing and treatment.
  • text: Design for care in multiple settings.

objections

  • objection: Is it FDA cleared for our intended use?
    response: The current site describes the product as investigational and not FDA cleared or approved; confirm the precise test and status before procurement or use.
  • objection: Will this fit our economics and reimbursement?
    response: Request test-specific pricing, payer coverage and workflow evidence; the site does not publish a price.

competitors

  • name: Lucira Health
    why: At-home molecular respiratory testing alternative.
  • name: Cue Health
    why: Developed a competing portable molecular diagnostics platform; check current availability.
  • name: Visby Medical
    why: Point-of-care molecular diagnostics competitor listed in a diagnostic platform company's SEC filing.

influencers

  • name: Cam Ball
    url: https://www.prnewswire.com/news-releases/scout-receives-funding-from-carb-x-to-develop-a-low-cost-point-of-care-and-home-diagnostic-for-gonorrhea-and-chlamydia-302120321.html
    why: Scout co-founder and CTO discussing the STI testing program.

keywords

  • point of care molecular testing
  • rapid chlamydia gonorrhea test
  • portable NAAT testing
  • near patient PCR alternative
  • at home molecular diagnostics
  • sexual health rapid diagnostics

voice

  • Clinical and evidence-oriented
  • Accessible
  • Outcome-focused

signals

  • text: Clinic seeks same-visit STI testing to reduce loss to follow-up.
  • text: Community care organization expands services in locations without nearby lab infrastructure.

pricing

model: unknown

motion

sales_led

channels

  • website waitlist
  • press
  • LinkedIn

confidence

medium

Founders

  • name: Alex Jiao
    title: Founder/CEO
    role: CEO
    bio: Bioengineering PhD trained in stem cell biology & tissue engineering (cardiac & skeletal muscle) and now in molecular diagnostics. Worked in biopharma therapy development (small molecule, biologics, gene therapy). Started and Silene Biotech and now working at Scout (formerly Uh-Oh Labs) as President and Chief Business Officer.
  • name: Cameron Ball
    title: Founder
    role: Founder
    bio: Cam is an accomplished biomedical engineer and entrepreneur. Before starting Uh-Oh Labs, Cameron worked at Sandia National Laboratories. Cameron is an expert in molecular diagnostics, microfluidics, materials science, and drug delivery. With 12 years of experience as a biomedical engineer, he brings a command of cross-functional engineering skills and fundamental science knowledge to bear on complex problems in biological systems.

Back to YC companies